Seller: GreatBookPrices, Columbia, MD, U.S.A.
Condition: New.
PAP. Condition: New. New Book. Shipped from UK. Established seller since 2000.
Seller: GreatBookPrices, Columbia, MD, U.S.A.
Condition: As New. Unread book in perfect condition.
Condition: New. pages cm.
Condition: New.
Condition: New. In.
Seller: GreatBookPricesUK, Woodford Green, United Kingdom
Condition: New.
Seller: Chiron Media, Wallingford, United Kingdom
paperback. Condition: New.
Condition: New. pages cm First edition Includes bibliographical references and index.
Seller: GreatBookPricesUK, Woodford Green, United Kingdom
Condition: As New. Unread book in perfect condition.
Seller: Kennys Bookshop and Art Galleries Ltd., Galway, GY, Ireland
First Edition
Condition: New. 2024. 1st Edition. paperback. . . . . .
Published by Taylor and Francis Ltd, GB, 2024
ISBN 10: 1032262028 ISBN 13: 9781032262024
Language: English
Seller: Rarewaves.com USA, London, LONDO, United Kingdom
Paperback. Condition: New. Biologics and Biosimilars: Drug Discovery and Clinical Applications is a systematic integration and evaluation of all aspects of biologics and biosimilars, encompassing research and development, clinical use, global regulation, and more. Biosimilars are biological therapeutic agents designed to imitate a reference biologic with high similarities in structure, efficacy, and safety, but also with potential clinical effective and cost-efficient options for the manufacturers, payers, clinicians, and patients. Most of the top-selling prescription drugs in the current market are biologics, which have revolutionized the treatment strategies and modalities for life-threatening and/or rare diseases.This book outlines the key processes and challenges in drug development, regulations, and clinical applications of biologics, biosimilars, and even interchangeable biosimilars. Global experts in the field discuss essential categories and prototype drugs of biologics and biosimilars in clinical practice such as allergenics, blood and blood components, cell treatment, gene therapy, recombinant therapeutic proteins or peptides, tissues, and vaccines.Additional features: Integrates the latest bench and bedside evidence of drug development and regulations of biologics and biosimilars Contains key study questions for each chapter to guide the readers, as well as drug charts for all therapeutic applications of biologics and biosimilars Presents detailed schematic illustrations to explain the drug development, clinical trials, regulations, and clinical applications of biologics and biosimilarsThis book is an invaluable tool for health care professional students, providers, and pharmaceutical and health care industries, as well as the public, providing readers with educational updates about the drug development and clinical affairs of biological medications and their similar drugs.
Condition: New. pages cm.
Published by Taylor & Francis Ltd, 2024
ISBN 10: 1032262028 ISBN 13: 9781032262024
Language: English
Seller: THE SAINT BOOKSTORE, Southport, United Kingdom
Other book format. Condition: New. New copy - Usually dispatched within 4 working days. 975.
Seller: Revaluation Books, Exeter, United Kingdom
Paperback. Condition: Brand New. 528 pages. 10.00x7.00x10.00 inches. In Stock.
Seller: Kennys Bookstore, Olney, MD, U.S.A.
Condition: New. 2024. 1st Edition. paperback. . . . . . Books ship from the US and Ireland.
Published by Taylor & Francis Ltd, London, 2024
ISBN 10: 1032262028 ISBN 13: 9781032262024
Language: English
Seller: CitiRetail, Stevenage, United Kingdom
Paperback. Condition: new. Paperback. Biologics and Biosimilars: Drug Discovery and Clinical Applications is a systematic integration and evaluation of all aspects of biologics and biosimilars, encompassing research and development, clinical use, global regulation, and more. Biosimilars are biological therapeutic agents designed to imitate a reference biologic with high similarities in structure, efficacy, and safety, but also with potential clinical effective and cost-efficient options for the manufacturers, payers, clinicians, and patients. Most of the top-selling prescription drugs in the current market are biologics, which have revolutionized the treatment strategies and modalities for life-threatening and/or rare diseases.This book outlines the key processes and challenges in drug development, regulations, and clinical applications of biologics, biosimilars, and even interchangeable biosimilars. Global experts in the field discuss essential categories and prototype drugs of biologics and biosimilars in clinical practice such as allergenics, blood and blood components, cell treatment, gene therapy, recombinant therapeutic proteins or peptides, tissues, and vaccines.Additional features: Integrates the latest bench and bedside evidence of drug development and regulations of biologics and biosimilars Contains key study questions for each chapter to guide the readers, as well as drug charts for all therapeutic applications of biologics and biosimilars Presents detailed schematic illustrations to explain the drug development, clinical trials, regulations, and clinical applications of biologics and biosimilarsThis book is an invaluable tool for health care professional students, providers, and pharmaceutical and health care industries, as well as the public, providing readers with educational updates about the drug development and clinical affairs of biological medications and their similar drugs. This is a good book designed mainly to give students and clinicians a quick overview of the science, principles, and applications of biologics and biosimilars. It is a useful tool in the clinic setting. - Victor Nwoko, BA, PharmD, Lifespring Pharmacy Inc. Shipping may be from our UK warehouse or from our Australian or US warehouses, depending on stock availability.
Condition: NEW.
Published by Taylor & Francis Ltd, London, 2024
ISBN 10: 1032262028 ISBN 13: 9781032262024
Language: English
Seller: AussieBookSeller, Truganina, VIC, Australia
Paperback. Condition: new. Paperback. Biologics and Biosimilars: Drug Discovery and Clinical Applications is a systematic integration and evaluation of all aspects of biologics and biosimilars, encompassing research and development, clinical use, global regulation, and more. Biosimilars are biological therapeutic agents designed to imitate a reference biologic with high similarities in structure, efficacy, and safety, but also with potential clinical effective and cost-efficient options for the manufacturers, payers, clinicians, and patients. Most of the top-selling prescription drugs in the current market are biologics, which have revolutionized the treatment strategies and modalities for life-threatening and/or rare diseases.This book outlines the key processes and challenges in drug development, regulations, and clinical applications of biologics, biosimilars, and even interchangeable biosimilars. Global experts in the field discuss essential categories and prototype drugs of biologics and biosimilars in clinical practice such as allergenics, blood and blood components, cell treatment, gene therapy, recombinant therapeutic proteins or peptides, tissues, and vaccines.Additional features: Integrates the latest bench and bedside evidence of drug development and regulations of biologics and biosimilars Contains key study questions for each chapter to guide the readers, as well as drug charts for all therapeutic applications of biologics and biosimilars Presents detailed schematic illustrations to explain the drug development, clinical trials, regulations, and clinical applications of biologics and biosimilarsThis book is an invaluable tool for health care professional students, providers, and pharmaceutical and health care industries, as well as the public, providing readers with educational updates about the drug development and clinical affairs of biological medications and their similar drugs. This is a good book designed mainly to give students and clinicians a quick overview of the science, principles, and applications of biologics and biosimilars. It is a useful tool in the clinic setting. - Victor Nwoko, BA, PharmD, Lifespring Pharmacy Inc. Shipping may be from our Sydney, NSW warehouse or from our UK or US warehouse, depending on stock availability.
Seller: Revaluation Books, Exeter, United Kingdom
Paperback. Condition: Brand New. 528 pages. 10.00x7.00x10.00 inches. In Stock.
Seller: Books From California, Simi Valley, CA, U.S.A.
hardcover. Condition: Very Good. Cover and edges may have some wear. Clean, unmarked copy.
Condition: New. Xiaodong Feng, Hong-Guang Xie, Ashim Malhotra, Catherine F. YangBiologics and Biosimilars: Drug Discovery and Clinical Applications is a systematic integration and evaluation of all aspects of biologics and biosimilars, encompassing research.
Seller: preigu, Osnabrück, Germany
Taschenbuch. Condition: Neu. Biologics and Biosimilars | Drug Discovery and Clinical Applications | Hong-Guang Xie (u. a.) | Taschenbuch | Einband - flex.(Paperback) | Englisch | 2024 | CRC Press | EAN 9781032262024 | Verantwortliche Person für die EU: Libri GmbH, Europaallee 1, 36244 Bad Hersfeld, gpsr[at]libri[dot]de | Anbieter: preigu.
Published by Taylor and Francis Ltd, GB, 2024
ISBN 10: 1032262028 ISBN 13: 9781032262024
Language: English
Seller: Rarewaves.com UK, London, United Kingdom
Paperback. Condition: New. Biologics and Biosimilars: Drug Discovery and Clinical Applications is a systematic integration and evaluation of all aspects of biologics and biosimilars, encompassing research and development, clinical use, global regulation, and more. Biosimilars are biological therapeutic agents designed to imitate a reference biologic with high similarities in structure, efficacy, and safety, but also with potential clinical effective and cost-efficient options for the manufacturers, payers, clinicians, and patients. Most of the top-selling prescription drugs in the current market are biologics, which have revolutionized the treatment strategies and modalities for life-threatening and/or rare diseases.This book outlines the key processes and challenges in drug development, regulations, and clinical applications of biologics, biosimilars, and even interchangeable biosimilars. Global experts in the field discuss essential categories and prototype drugs of biologics and biosimilars in clinical practice such as allergenics, blood and blood components, cell treatment, gene therapy, recombinant therapeutic proteins or peptides, tissues, and vaccines.Additional features: Integrates the latest bench and bedside evidence of drug development and regulations of biologics and biosimilars Contains key study questions for each chapter to guide the readers, as well as drug charts for all therapeutic applications of biologics and biosimilars Presents detailed schematic illustrations to explain the drug development, clinical trials, regulations, and clinical applications of biologics and biosimilarsThis book is an invaluable tool for health care professional students, providers, and pharmaceutical and health care industries, as well as the public, providing readers with educational updates about the drug development and clinical affairs of biological medications and their similar drugs.
Published by Taylor & Francis Group, 2022
ISBN 10: 1138594229 ISBN 13: 9781138594227
Language: English
Seller: Books Puddle, New York, NY, U.S.A.
Condition: New. 1st edition NO-PA16APR2015-KAP.
Published by Taylor & Francis Group, 2022
ISBN 10: 1138594229 ISBN 13: 9781138594227
Language: English
Seller: Majestic Books, Hounslow, United Kingdom
Condition: New.
Seller: GreatBookPrices, Columbia, MD, U.S.A.
Condition: New.
Seller: Lucky's Textbooks, Dallas, TX, U.S.A.
Condition: New.
Published by Taylor & Francis Group, 2022
ISBN 10: 1138594229 ISBN 13: 9781138594227
Language: English
Seller: Biblios, Frankfurt am main, HESSE, Germany
Condition: New.
Seller: California Books, Miami, FL, U.S.A.
Condition: New.